Your browser doesn't support javascript.
loading
Severe Acute Respiratory Syndrome Coronavirus 2 Third Vaccine Immune Response in Multiple Sclerosis Patients Treated with Ocrelizumab.
Brill, Livnat; Raposo, Catarina; Rechtman, Ariel; Zveik, Omri; Levin, Netta; Oiknine-Djian, Esther; Wolf, Dana G; Vaknin-Dembinsky, Adi.
Afiliación
  • Brill L; Department of Neurology, Laboratory of Neuroimmunology, and Agnes-Ginges Center for Neurogenetics, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Raposo C; F. Hoffmann-La Roche, Basel, Switzerland.
  • Rechtman A; Department of Neurology, Laboratory of Neuroimmunology, and Agnes-Ginges Center for Neurogenetics, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Zveik O; Department of Neurology, Laboratory of Neuroimmunology, and Agnes-Ginges Center for Neurogenetics, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Levin N; Department of Neurology, Laboratory of Neuroimmunology, and Agnes-Ginges Center for Neurogenetics, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Oiknine-Djian E; Clinical Virology Unit, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
  • Wolf DG; Lautenberg Center for General and Tumor Immunology, Hebrew University Faculty of Medicine, Jerusalem, Israel.
  • Vaknin-Dembinsky A; Clinical Virology Unit, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
Ann Neurol ; 91(6): 796-800, 2022 06.
Article en En | MEDLINE | ID: mdl-35243687

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: COVID-19 / Esclerosis Múltiple Límite: Humans Idioma: En Revista: Ann Neurol Año: 2022 Tipo del documento: Article País de afiliación: Israel

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: COVID-19 / Esclerosis Múltiple Límite: Humans Idioma: En Revista: Ann Neurol Año: 2022 Tipo del documento: Article País de afiliación: Israel